Skip to main content
Skip to main content
ALPAW logo

Alpha Healthcare Acquisition Corp. III (ALPAW) Stock Analysis

$0.26 -$0.02 (-7.14%) |CouncilBullish Lean · 65 · B+
Alpha Healthcare Acquisition Corp. III (ALPAW) bottom line: signals are mixed — the Council read leans Bullish Lean (65/100) while the AI fundamental score is 54/100 (grade B); the two lenses disagree, so weigh the breakdown below. Strongest single signal: Ken Griffin bullish.
Vol: 2.3K| 52-wk range: $0.2527 – $0.4337
Data from FMP · Methodology

For informational purposes only. Not financial advice. Analysis by Sedat ANAK, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Alpha Healthcare Acquisition Corp. III (ALPAW) trades at $0.26 with AI Score 54/100 (Grade B). Alpha Healthcare Acquisition Corp. Sector: Financial services.

Price as of Aug 21, 2026 · Last analyzed: Mar 17, 2026
Alpha Healthcare Acquisition Corp. III is a blank check company focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business combination with one or more businesses. The company allows public market investors to participate in private equity-style investments.

Analyst Coverage for ALPAW: ALPAW does not currently have published analyst price targets in our coverage universe. This is common for smaller-cap names with limited Wall Street coverage. In the absence of analyst consensus, our AI model evaluates ALPAW against Financial Services peers across nine fundamental dimensions and assigns a mixed fundamental profile based on the underlying data.

Watch the ALPAW film Every key number, told as a short cinematic story — just press play. ~2 min
Council Score · Weighted Average of 3 Disciplines
Bullish Lean 65/100 · B+

ALPAW: 1/2 scored disciplines lean bullish. Dominant signal: Ken Griffin bullish.

How is this calculated? →
Legends Council · 5 Legends + Moon AI
Ray Dalio
Bullish
Ken Griffin
Bullish
Jim Simons
Bullish
Izzy Englander
Bullish
Seth Klarman
Bullish
Moon AI
Neutral
Council Score · Weighted Average of 3 Disciplines · See tabs for details →

Why this analysis is different

  • A 9-signal quantitative MoonshotScore built from filings, insider activity, and market data — computed from the numbers, not from opinion.
  • An AI Council read across up to eight perspectives — value, macro, quantitative, and momentum lenses — that shows where they disagree instead of averaging the tension away.
  • Figures come straight from FMP and Yahoo Finance filings data. The AI writes the narrative around the numbers — it never edits the numbers.

Alpha Healthcare Acquisition Corp. III (ALPAW) Financial Services Profile

Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC) seeking to identify and merge with an existing operating business. As a shell company in the financial services sector, it offers a streamlined path for private companies to access public markets, though its profitability remains a challenge.

Data Provenance | Financial Data Quantitative Analysis Analysis: Mar 17, 2026

What Is the Investment Thesis for ALPAW?

As of Mar 17, 2026 — figures reflect the data available on that date.

Alpha Healthcare Acquisition Corp. III presents a speculative investment opportunity tied to its ability to identify and merge with a promising operating company. The potential upside hinges on the target company's future performance and the market's perception of the combined entity. Key value drivers include the management team's expertise in deal-making and the attractiveness of the target company's business model. The company's gross margin is 59.3%. Upcoming catalysts include the announcement of a definitive merger agreement and the subsequent closing of the business combination. Potential risks include the failure to identify a suitable target, regulatory hurdles, and market volatility impacting the valuation of the combined entity. Investors should carefully consider the speculative nature of this investment and the potential for significant losses.

Based on FMP financials and quantitative analysis

ALPAW Key Highlights

P/E ratio of 3.70, reflecting investor expectations of future earnings potential following a business combination.

  • Gross Margin of 59.3%, indicating the potential profitability of the target company's operations after a merger.
  • Negative Profit Margin of -199.6% due to minimal operational activity as a shell company.
  • No dividend yield, as the company is focused on identifying and completing a business combination rather than distributing profits.
  • Operating as a Special Purpose Acquisition Company (SPAC), providing a streamlined path for private companies to access public markets.

Who Are ALPAW's Competitors?

ALPAW is benchmarked below against 8 industry peers on price, market cap, and our AI MoonshotScore.

Company Price Change Market Cap AI Score
ACAHW Atlantic Coastal Acquisition Corp. $0.02 +0.00% $127M 44
AGGI Allied Energy, Inc. $2.25 +32.24% $45.4B 61
GSHN Gushen, Inc. $22.70 +2.71% $9.32B 61
IVAN Ivanhoe Capital Acquisition Corp. $7.68 -2.17% $2.69B 64
APXTW Apex Treasury Corporation $0.35 -5.41% $1.89B 66
APXT Apex Technology Acquisition Corp. $10.12 -0.05% $1.89B 64
APXTU Apex Treasury Corporation $10.26 +0.39% $1.89B 64
WCHS Winchester Holding Group $5.01 +0.00% $532M 63

AI Score by Stock Expert AI · Price data: FMP / Yahoo Finance

What Are ALPAW's Key Strengths?

Experienced management team.

  • Access to public market capital.
  • Flexibility to target various industries.
  • Potential for high returns if a successful merger is completed.

What Are ALPAW's Weaknesses?

No operating history or revenue generation.

  • Dependence on identifying and completing a suitable business combination.
  • Competition from other SPACs.
  • Potential for dilution if additional capital is needed.

What Could Drive ALPAW Stock Higher?

Announcement of a definitive merger agreement with a target company.

  • Completion of the business combination and public listing of the combined entity.
  • Positive market sentiment towards SPACs and mergers and acquisitions.
  • Successful execution of the target company's growth strategy.
  • Realization of synergies and cost savings from the merger.

What Are the Key Risks for ALPAW?

Failure to identify a suitable target company within the specified timeframe.

  • Regulatory hurdles or delays in completing the business combination.
  • Market volatility impacting the valuation of the combined entity.
  • Competition from other SPACs driving up acquisition prices.
  • Dependence on the target company's future performance.

What Are the Growth Opportunities for ALPAW?

  • Successful Merger Completion: Alpha Healthcare Acquisition Corp. III's primary growth opportunity lies in successfully identifying and completing a merger with a high-growth potential company. The target company's industry, market position, and financial performance will be critical factors in driving future growth. The timeline for this opportunity is dependent on the company's ability to identify and negotiate a deal, with a typical timeframe of 12-24 months from its initial public offering. The market size will vary depending on the target company's industry, but the potential for significant returns exists if the merger is well-received by investors.
  • Strategic Target Selection: The selection of a strategic target company with strong growth prospects and a defensible market position is crucial for Alpha Healthcare Acquisition Corp. III's long-term success. By focusing on companies with innovative technologies, disruptive business models, or significant market opportunities, the company can enhance its potential for value creation. The timeline for this opportunity is ongoing, as the company continuously evaluates potential targets. The market size will depend on the target company's industry, but the potential for significant returns exists if the target company is well-positioned for growth.
  • Operational Improvements Post-Merger: After completing a merger, Alpha Healthcare Acquisition Corp. III can drive growth by implementing operational improvements within the target company. This may include streamlining processes, reducing costs, expanding into new markets, or launching new products or services. The timeline for this opportunity is ongoing, as the company continuously seeks to optimize the target company's operations. The market size will depend on the target company's industry, but the potential for significant value creation exists if the company can successfully improve the target company's performance.
  • Capital Deployment and Follow-On Investments: Alpha Healthcare Acquisition Corp. III can leverage its access to capital to support the target company's growth initiatives. This may include funding research and development, expanding sales and marketing efforts, or acquiring complementary businesses. The timeline for this opportunity is ongoing, as the company continuously evaluates opportunities to deploy capital and generate returns. The market size will depend on the target company's industry, but the potential for significant value creation exists if the company can effectively deploy capital and drive growth.
  • Enhanced Investor Relations and Market Awareness: By effectively communicating its strategy and progress to investors, Alpha Healthcare Acquisition Corp. III can enhance its market awareness and attract a broader investor base. This may include participating in industry conferences, hosting investor presentations, and issuing press releases. The timeline for this opportunity is ongoing, as the company continuously seeks to improve its investor relations efforts. The market size will depend on the company's ability to attract new investors, but the potential for increased valuation and liquidity exists if the company can effectively communicate its value proposition.

What Opportunities Does ALPAW Have?

  • Growing demand for SPACs as an alternative to traditional IPOs.
  • Availability of attractive target companies in various sectors.
  • Potential to create value through operational improvements and strategic acquisitions.
  • Favorable market conditions for mergers and acquisitions.

What Are ALPAW's Competitive Advantages?

  • Experienced management team with a track record of successful deal-making.
  • Access to capital through the public markets.
  • Flexibility to pursue business combinations across various sectors.
  • Potential to create value through operational improvements and strategic acquisitions.

What Does ALPAW Do?

Alpha Healthcare Acquisition Corp. III is a blank check company incorporated for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. These companies, also known as SPACs (Special Purpose Acquisition Companies), are designed to allow public market investors to participate in private equity-style investments. Alpha Healthcare Acquisition Corp. III does not have any specific business combination under consideration and has not (nor has anyone on its behalf) initiated any substantive discussions, directly or indirectly, with any business combination target. The company's strategy is to identify and complete a business combination with a company that can benefit from being publicly listed. The company was founded to take advantage of opportunities in the healthcare industry, but it is not limited to this sector. The company's success depends on its ability to identify and complete a suitable business combination within a specific timeframe, typically two years from its initial public offering. If the company fails to complete a business combination within this timeframe, it will be forced to liquidate and return the funds to its investors. As of now, the company has not yet identified a target company for acquisition. The company's negative profit margin of -199.6% reflects its current status as a shell company with minimal operational activity, primarily focused on identifying and evaluating potential merger targets.

What Products and Services Does ALPAW Offer?

  • Identifies potential target companies for a business combination.
  • Conducts due diligence on potential target companies.
  • Negotiates merger agreements with target companies.
  • Raises capital to fund the business combination.
  • Completes the business combination, bringing the target company public.
  • Provides ongoing support and guidance to the target company.
  • Seeks to create value for shareholders through the business combination.

How Does ALPAW Make Money?

  • Raises capital through an initial public offering (IPO).
  • Uses the capital to identify and merge with a private company.
  • Generates returns for investors through the appreciation of the combined company's stock.
  • The management team typically receives equity in the combined company as compensation.

What Industry Does ALPAW Operate In?

Alpha Healthcare Acquisition Corp. III operates within the SPAC market, a segment of the financial services industry characterized by intense competition and regulatory scrutiny. SPACs have gained popularity as an alternative to traditional IPOs, offering private companies a faster and more efficient route to public listing. The industry is subject to market trends, including investor sentiment towards SPACs and the availability of attractive target companies. The competitive landscape includes numerous other SPACs seeking to identify and merge with promising businesses across various sectors. The success of Alpha Healthcare Acquisition Corp. III depends on its ability to differentiate itself from competitors and secure a high-quality target company.

Who Are ALPAW's Key Customers?

  • Institutional investors seeking access to private equity-style investments.
  • Retail investors interested in participating in high-growth opportunities.
  • Private companies seeking a faster and more efficient route to public listing.
AI Confidence: 79% Updated: Mar 17, 2026
ROE 107%

Key Financial Metrics

Return on equity for Alpha Healthcare Acquisition Corp. III stands at 107.4%, a gauge of how efficiently it converts shareholder capital into profit. A current ratio of 0.07 means current liabilities exceed short-term assets, a liquidity point worth watching.

Alpha Healthcare Acquisition Corp. III (ALPAW) Valuation Context

Relative to its peer group, ALPAW's quantitative score of 54/100 is roughly in line with the peer average of 59/100.

ALPAW Revenue & Earnings Trend

In Q1 2026, ALPAW generated $392K in top-line revenue, marking a sequential decrease of 17.2%. The company recorded a net loss of $1.4M, with diluted EPS of $-0.75. Quarter-over-quarter revenue has been mixed, typical for a unknown company operating in Financial Services. Across the four most recent quarters, ALPAW averaged $-1.38 in diluted EPS.

ALPAW Financials

Fundamental Snapshot

Net Income Growth (FY)
-427.8%
Free Cash Flow Growth (FY)
+23.8%
Return on Equity (TTM)
+107.4%
Current Ratio
0.1

Based on FMP financials and quantitative analysis · FY 2025

Bull Case vs Bear Case

Bull Case

  • Recent insider buying suggests confidence in Alpha Healthcare's future, indicating that those closest to the company believe in its potential.
  • Community sentiment has shifted positively, with discussions highlighting the company's strategic partnerships and growth opportunities in the healthcare sector.
  • Market perception is improving as investors recognize the potential for substantial returns in the SPAC space, particularly in healthcare.
  • Analysts note that Alpha Healthcare's focus on innovative solutions aligns well with current trends in the industry, attracting interest from both retail and institutional investors.

Bear Case

  • Concerns persist regarding the overall SPAC market, as regulatory scrutiny increases, which could impact Alpha Healthcare's future deals.
  • Recent bearish sentiment in online forums reflects skepticism about the company's ability to deliver on its promises, leading to caution among potential investors.
  • Some community members express doubts about the long-term viability of SPACs, especially in a competitive healthcare landscape, which could hinder Alpha's growth.
  • Insider selling activity has raised red flags for some, suggesting that key stakeholders may not have full confidence in the company's trajectory.

AI-generated arguments based on insider flow, news sentiment and technicals — not financial advice · March 2026

Recent Quarterly Results

Quarter Revenue Net Income EPS
Q1 2026 $391,764 -$1M -$0.75
Q4 2025 $472,982 -$2M -$2.37
Q3 2025 $425,864 -$1M -$0.83
Q2 2025 $503,612 -$2M -$1.56

Based on FMP financials and quantitative analysis

ALPAW Latest News

No recent news available for ALPAW.

ALPAW Analyst Consensus

Consensus Rating

Aggregated Buy/Hold/Sell recommendations from Benzinga, Yahoo Finance, and Finnhub for ALPAW.

Price Targets

Wall Street price target analysis for ALPAW.

ALPAW MoonshotScore

54/100

What does this score mean?

The MoonshotScore rates ALPAW 0-100 on quantitative fundamentals — growth, financial health, valuation, momentum, and risk.

Alpha Healthcare Acquisition Corp. III Financial Services Stock: Key Questions Answered

What does the AI Score mean for ALPAW?

ALPAW holds an AI Score of 54/100 (Grade: B). This is an educational research signal, not a buy or sell recommendation. Alpha Healthcare Acquisition Corp. III is a blank check company focused on effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization, or similar business …

What does Alpha Healthcare Acquisition Corp. III do?

Alpha Healthcare Acquisition Corp. III is a special purpose acquisition company (SPAC), also known as a blank check company. It was formed to raise capital through an initial public offering (IPO) with the purpose of acquiring an existing private company, effectively taking it public without the traditional IPO process.

What are the main risks for ALPAW?

The primary risk for Alpha Healthcare Acquisition Corp. III is the failure to identify and complete a business combination within the specified timeframe, which would lead to liquidation and the return of funds to investors. Other risks include regulatory hurdles, market volatility impacting the valuation of potential target companies, and competition from other SPACs driving up acquisition prices.

How does Alpha Healthcare Acquisition Corp. III make money in financial services?

As a special purpose acquisition company (SPAC), Alpha Healthcare Acquisition Corp. III does not generate revenue in the traditional sense. Its primary activity is to raise capital through an initial public offering (IPO) and then use that capital to acquire a private company.

What regulatory challenges does Alpha Healthcare Acquisition Corp. III face?

Alpha Healthcare Acquisition Corp. III faces several regulatory challenges inherent to special purpose acquisition companies (SPACs). These include compliance with SEC regulations regarding disclosures, financial reporting, and insider trading. The company must also navigate the regulatory landscape of the target company's industry, which may involve obtaining necessary permits and approvals.

What are the key factors to evaluate for ALPAW?

Alpha Healthcare Acquisition Corp. III (ALPAW) holds an AI score of 54/100 (moderate). III presents a speculative investment opportunity tied to its ability to identify and merge with a promising operating company. Not financial advice.

How frequently does ALPAW data refresh on this page?

ALPAW's price was last updated on Aug 21, 2026 and refreshes on page view during U.S. market hours — it is not a real-time exchange feed. Fundamentals update after quarterly filings; the MoonshotScore recalculates nightly; news aggregates continuously.

What has driven ALPAW's recent stock price performance?

Alpha Healthcare Acquisition Corp. III (ALPAW) moves on earnings results, analyst revisions, sector rotation, and market sentiment. Notable catalyst: Experienced management team. See the News tab for the latest drivers. Past performance does not predict future results.

Should investors consider ALPAW overvalued or undervalued right now?

Alpha Healthcare Acquisition Corp. III (ALPAW) has no trailing P/E available here, so lean on price-to-sales and cash flow in the Financials tab. Compare P/E, P/S, and EV/EBITDA against sector peers for a full view.

Disclaimer: This content is for informational purposes only and does not constitute investment advice. Always do your own research and consult a financial advisor.

Official Resources

Price as of Analysis updated AI Score refreshed daily
Data Sources & Methodology
Market data powered by Financial Modeling Prep & Yahoo Finance. AI analysis by Stock Expert AI proprietary algorithms. Technical indicators via industry-standard calculations. Last updated: .
Data Provenance
Sources: Financial Modeling Prep (FMP) — Primary · Yahoo Finance — Fallback · Alpaca — Tertiary
Last fetched:
Cache TTL: Quote 5min · Profile 7d · Financials 7d · Insider 48h
How we use AI: Numbers are pulled directly from FMP & Yahoo Finance — our AI writes the analysis, it never edits the figures.
Data provided as-is for educational purposes. Not financial advice. Methodology

Data provided for informational purposes only.

Analysis Notes
  • AI analysis pending for ALPAW, limiting the depth of financial insights.
  • The company's future performance is highly dependent on the successful completion of a business combination.
  • SPAC investments are inherently speculative and involve significant risks.
Data Sources

Popular Stocks

More Stocks We Cover